![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: RBPJ |
Gene summary for RBPJ |
![]() |
Gene information | Species | Human | Gene symbol | RBPJ | Gene ID | 3516 |
Gene name | recombination signal binding protein for immunoglobulin kappa J region | |
Gene Alias | AOS3 | |
Cytomap | 4p15.2 | |
Gene Type | protein-coding | GO ID | GO:0000003 | UniProtAcc | Q06330 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
3516 | RBPJ | LZE2T | Human | Esophagus | ESCC | 1.28e-12 | 4.94e-01 | 0.082 |
3516 | RBPJ | LZE3D | Human | Esophagus | HGIN | 4.44e-04 | 4.43e-01 | 0.0668 |
3516 | RBPJ | LZE4T | Human | Esophagus | ESCC | 1.15e-04 | 2.85e-01 | 0.0811 |
3516 | RBPJ | LZE7T | Human | Esophagus | ESCC | 1.37e-03 | 5.57e-01 | 0.0667 |
3516 | RBPJ | LZE8T | Human | Esophagus | ESCC | 1.34e-07 | 2.53e-01 | 0.067 |
3516 | RBPJ | LZE20T | Human | Esophagus | ESCC | 2.16e-07 | 1.59e-01 | 0.0662 |
3516 | RBPJ | LZE22D1 | Human | Esophagus | HGIN | 5.77e-04 | 2.03e-02 | 0.0595 |
3516 | RBPJ | LZE22T | Human | Esophagus | ESCC | 2.45e-02 | 3.96e-02 | 0.068 |
3516 | RBPJ | LZE24T | Human | Esophagus | ESCC | 3.44e-13 | 2.17e-01 | 0.0596 |
3516 | RBPJ | LZE21T | Human | Esophagus | ESCC | 7.37e-04 | 1.26e-01 | 0.0655 |
3516 | RBPJ | LZE6T | Human | Esophagus | ESCC | 6.25e-08 | 2.68e-01 | 0.0845 |
3516 | RBPJ | P1T-E | Human | Esophagus | ESCC | 7.56e-07 | 1.87e-01 | 0.0875 |
3516 | RBPJ | P2T-E | Human | Esophagus | ESCC | 5.84e-26 | 5.97e-01 | 0.1177 |
3516 | RBPJ | P4T-E | Human | Esophagus | ESCC | 1.93e-20 | 5.60e-01 | 0.1323 |
3516 | RBPJ | P5T-E | Human | Esophagus | ESCC | 5.96e-20 | 1.18e-01 | 0.1327 |
3516 | RBPJ | P8T-E | Human | Esophagus | ESCC | 1.06e-21 | 7.23e-01 | 0.0889 |
3516 | RBPJ | P9T-E | Human | Esophagus | ESCC | 6.13e-13 | 2.29e-01 | 0.1131 |
3516 | RBPJ | P10T-E | Human | Esophagus | ESCC | 7.18e-26 | 6.12e-01 | 0.116 |
3516 | RBPJ | P11T-E | Human | Esophagus | ESCC | 1.96e-14 | 6.07e-01 | 0.1426 |
3516 | RBPJ | P12T-E | Human | Esophagus | ESCC | 3.10e-16 | 5.14e-01 | 0.1122 |
Page: 1 2 3 4 5 6 7 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:000150331 | Oral cavity | NEOLP | ossification | 81/2005 | 408/18723 | 2.67e-08 | 1.15e-06 | 81 |
GO:000189231 | Oral cavity | NEOLP | embryonic placenta development | 27/2005 | 82/18723 | 5.12e-08 | 2.08e-06 | 27 |
GO:003300221 | Oral cavity | NEOLP | muscle cell proliferation | 55/2005 | 248/18723 | 1.11e-07 | 4.03e-06 | 55 |
GO:006082831 | Oral cavity | NEOLP | regulation of canonical Wnt signaling pathway | 55/2005 | 253/18723 | 2.23e-07 | 7.28e-06 | 55 |
GO:007048232 | Oral cavity | NEOLP | response to oxygen levels | 69/2005 | 347/18723 | 2.66e-07 | 8.54e-06 | 69 |
GO:000166632 | Oral cavity | NEOLP | response to hypoxia | 63/2005 | 307/18723 | 2.75e-07 | 8.78e-06 | 63 |
GO:000717822 | Oral cavity | NEOLP | transmembrane receptor protein serine/threonine kinase signaling pathway | 70/2005 | 355/18723 | 3.04e-07 | 9.62e-06 | 70 |
GO:003629332 | Oral cavity | NEOLP | response to decreased oxygen levels | 65/2005 | 322/18723 | 3.34e-07 | 1.04e-05 | 65 |
GO:006007031 | Oral cavity | NEOLP | canonical Wnt signaling pathway | 62/2005 | 303/18723 | 3.79e-07 | 1.15e-05 | 62 |
GO:001982721 | Oral cavity | NEOLP | stem cell population maintenance | 34/2005 | 131/18723 | 6.89e-07 | 1.93e-05 | 34 |
GO:004362032 | Oral cavity | NEOLP | regulation of DNA-templated transcription in response to stress | 19/2005 | 53/18723 | 1.11e-06 | 2.91e-05 | 19 |
GO:009872721 | Oral cavity | NEOLP | maintenance of cell number | 34/2005 | 134/18723 | 1.21e-06 | 3.13e-05 | 34 |
GO:006053723 | Oral cavity | NEOLP | muscle tissue development | 75/2005 | 403/18723 | 1.22e-06 | 3.15e-05 | 75 |
GO:009026331 | Oral cavity | NEOLP | positive regulation of canonical Wnt signaling pathway | 29/2005 | 106/18723 | 1.40e-06 | 3.56e-05 | 29 |
GO:190313122 | Oral cavity | NEOLP | mononuclear cell differentiation | 77/2005 | 426/18723 | 2.80e-06 | 6.41e-05 | 77 |
GO:004269221 | Oral cavity | NEOLP | muscle cell differentiation | 71/2005 | 384/18723 | 2.97e-06 | 6.76e-05 | 71 |
GO:004361831 | Oral cavity | NEOLP | regulation of transcription from RNA polymerase II promoter in response to stress | 17/2005 | 47/18723 | 3.52e-06 | 7.79e-05 | 17 |
GO:000315823 | Oral cavity | NEOLP | endothelium development | 33/2005 | 136/18723 | 4.94e-06 | 1.04e-04 | 33 |
GO:000183714 | Oral cavity | NEOLP | epithelial to mesenchymal transition | 36/2005 | 157/18723 | 7.50e-06 | 1.48e-04 | 36 |
GO:003017723 | Oral cavity | NEOLP | positive regulation of Wnt signaling pathway | 33/2005 | 140/18723 | 9.57e-06 | 1.82e-04 | 33 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0501727 | Esophagus | HGIN | Spinocerebellar ataxia | 43/1383 | 143/8465 | 2.68e-05 | 3.64e-04 | 2.89e-04 | 43 |
hsa0516930 | Esophagus | HGIN | Epstein-Barr virus infection | 55/1383 | 202/8465 | 5.13e-05 | 6.19e-04 | 4.92e-04 | 55 |
hsa052039 | Esophagus | HGIN | Viral carcinogenesis | 53/1383 | 204/8465 | 2.58e-04 | 2.71e-03 | 2.15e-03 | 53 |
hsa05017112 | Esophagus | HGIN | Spinocerebellar ataxia | 43/1383 | 143/8465 | 2.68e-05 | 3.64e-04 | 2.89e-04 | 43 |
hsa05169114 | Esophagus | HGIN | Epstein-Barr virus infection | 55/1383 | 202/8465 | 5.13e-05 | 6.19e-04 | 4.92e-04 | 55 |
hsa0520315 | Esophagus | HGIN | Viral carcinogenesis | 53/1383 | 204/8465 | 2.58e-04 | 2.71e-03 | 2.15e-03 | 53 |
hsa05169210 | Esophagus | ESCC | Epstein-Barr virus infection | 151/4205 | 202/8465 | 1.55e-13 | 3.45e-12 | 1.77e-12 | 151 |
hsa0516510 | Esophagus | ESCC | Human papillomavirus infection | 215/4205 | 331/8465 | 7.86e-09 | 7.12e-08 | 3.65e-08 | 215 |
hsa0520325 | Esophagus | ESCC | Viral carcinogenesis | 137/4205 | 204/8465 | 2.47e-07 | 1.88e-06 | 9.62e-07 | 137 |
hsa0501728 | Esophagus | ESCC | Spinocerebellar ataxia | 94/4205 | 143/8465 | 6.77e-05 | 2.90e-04 | 1.48e-04 | 94 |
hsa043306 | Esophagus | ESCC | Notch signaling pathway | 42/4205 | 62/8465 | 2.97e-03 | 7.97e-03 | 4.08e-03 | 42 |
hsa046585 | Esophagus | ESCC | Th1 and Th2 cell differentiation | 58/4205 | 92/8465 | 6.49e-03 | 1.60e-02 | 8.19e-03 | 58 |
hsa0516937 | Esophagus | ESCC | Epstein-Barr virus infection | 151/4205 | 202/8465 | 1.55e-13 | 3.45e-12 | 1.77e-12 | 151 |
hsa0516515 | Esophagus | ESCC | Human papillomavirus infection | 215/4205 | 331/8465 | 7.86e-09 | 7.12e-08 | 3.65e-08 | 215 |
hsa0520335 | Esophagus | ESCC | Viral carcinogenesis | 137/4205 | 204/8465 | 2.47e-07 | 1.88e-06 | 9.62e-07 | 137 |
hsa0501736 | Esophagus | ESCC | Spinocerebellar ataxia | 94/4205 | 143/8465 | 6.77e-05 | 2.90e-04 | 1.48e-04 | 94 |
hsa0433013 | Esophagus | ESCC | Notch signaling pathway | 42/4205 | 62/8465 | 2.97e-03 | 7.97e-03 | 4.08e-03 | 42 |
hsa0465812 | Esophagus | ESCC | Th1 and Th2 cell differentiation | 58/4205 | 92/8465 | 6.49e-03 | 1.60e-02 | 8.19e-03 | 58 |
hsa0501710 | Liver | Cirrhotic | Spinocerebellar ataxia | 66/2530 | 143/8465 | 2.58e-05 | 2.15e-04 | 1.32e-04 | 66 |
hsa05165 | Liver | Cirrhotic | Human papillomavirus infection | 124/2530 | 331/8465 | 1.55e-03 | 7.83e-03 | 4.83e-03 | 124 |
Page: 1 2 3 4 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 2 3 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
RBPJ | SNV | Missense_Mutation | c.1118N>C | p.Leu373Pro | p.L373P | Q06330 | protein_coding | deleterious(0.03) | probably_damaging(0.99) | TCGA-BH-A0E9-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | taxotere | CR | |
RBPJ | SNV | Missense_Mutation | rs141690523 | c.110G>A | p.Arg37Gln | p.R37Q | Q06330 | protein_coding | tolerated(0.22) | benign(0.006) | TCGA-A6-6141-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | 5-fu | SD |
RBPJ | SNV | Missense_Mutation | rs750670227 | c.31G>A | p.Glu11Lys | p.E11K | Q06330 | protein_coding | tolerated_low_confidence(0.48) | benign(0.001) | TCGA-AZ-6599-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
RBPJ | SNV | Missense_Mutation | c.149N>G | p.Ile50Ser | p.I50S | Q06330 | protein_coding | deleterious(0) | probably_damaging(0.988) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR | |
RBPJ | SNV | Missense_Mutation | rs141690523 | c.110G>A | p.Arg37Gln | p.R37Q | Q06330 | protein_coding | tolerated(0.22) | benign(0.006) | TCGA-CA-6718-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | PD |
RBPJ | SNV | Missense_Mutation | rs141690523 | c.110G>A | p.Arg37Gln | p.R37Q | Q06330 | protein_coding | tolerated(0.22) | benign(0.006) | TCGA-AG-3892-01 | Colorectum | rectum adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
RBPJ | SNV | Missense_Mutation | c.965T>C | p.Ile322Thr | p.I322T | Q06330 | protein_coding | deleterious(0) | probably_damaging(0.944) | TCGA-AG-3892-01 | Colorectum | rectum adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
RBPJ | SNV | Missense_Mutation | novel | c.455N>G | p.Asp152Gly | p.D152G | Q06330 | protein_coding | deleterious(0.01) | possibly_damaging(0.615) | TCGA-AG-A002-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
RBPJ | SNV | Missense_Mutation | novel | c.746N>C | p.Lys249Thr | p.K249T | Q06330 | protein_coding | tolerated(0.06) | probably_damaging(1) | TCGA-AG-A002-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
RBPJ | SNV | Missense_Mutation | novel | c.790A>C | p.Ile264Leu | p.I264L | Q06330 | protein_coding | deleterious(0) | possibly_damaging(0.875) | TCGA-F5-6814-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |